Deepa Chitre

Employment

• Bioved Pharmaceuticals, Inc. Chief Executive Officer
  2000 - Present

Education

• UCSF Medical Center MD
  1990 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (3)

• Phase III randomized clinical trial of BV‐4051, an Ayurvedic polyherbal formulation in moderate SARS‐CoV‐2 infections and its impact on inflammatory biomarkers
  Phytotherapy Research 2023 DOI: 10.1002/ptr.7683
  +Save
• Hepatoprotective Activity of BV‐7310, a Proprietary Herbal Formulation of Phyllanthus niruri, Tephrosia purpurea, Boerhavia diffusa, and Andrographis paniculata, in Alcohol‐Induced HepG2 Cells and Alcohol plus a Haloalkane, CCl4, Induced Liver Damage in …
  Evidence-Based Complementary and Alternative Medicine 2020 DOI: 10.1155/2020/6428906
  +Save
• Inhibition of LPS‐Induced TNF‐α and NO Production in Mouse Macrophage and Inflammatory Response in Rat Animal Models by a Novel Ayurvedic Formulation, BV‐9238
  Phytotherapy Research 2014 DOI: 10.1002/ptr.5151
  +Save